Email updates

Keep up to date with the latest news and content from HQLO and BioMed Central.

Open Access Highly Accessed Research

Psychological investigation in patients with polycystic ovary syndrome

Fatemeh Bazarganipour1, Saeide Ziaei1*, Ali Montazeri2, Fatemeh Foroozanfard3, Anoshirvan Kazemnejad4 and Soghrat Faghihzadeh5

Author Affiliations

1 Reproductive health and midwifery department, Tarbiat Modares University, Tehran, Iran

2 Mental Health Research Group, Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran

3 Gynecology and Obstetrics department, Kashan University of medical sciences, Kashan, Iran

4 Biostatistics department, Tarbiat Modares University, Tehran, Iran

5 Faculty of Medical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran

For all author emails, please log on.

Health and Quality of Life Outcomes 2013, 11:141  doi:10.1186/1477-7525-11-141

Published: 16 August 2013

Abstract

Background

The aim of the present study was to estimate the prevalence of mood disorders and examine a range of predictors for psychological well-being among Iranian women with polycystic ovary syndrome (PCOS).

Methods

A cross-sectional study was undertaken to ascertain the factors related to psychological distress in PCOS patients in Kashan, Iran. Psychological distress was measured using the Hospital Anxiety and Depression Scale (HADS). In addition we assessed quality of life using the Short Form Health Survey (SF-36). Socio-demographic details and clinical information of PCOS including obesity (body mass index), excessive body hair (hirsutism score), acne, menstrual cycle disturbances, infertility and endocrine profile also were recorded for each patient.

Results

In all 300 women with PCOS were entered into the study. Of these 32% (n =96) showed elevated HADS anxiety while depression was high in 5% (n =15). Quality of life was significantly impaired in women with anxiety (P <0.05), and depression (P <0.001) and in particular, in women with coexistence anxiety and depression (P <0.001) compared with unaffected participants. Compared with the non-depressed PCOS patients, the depressed women had significantly higher menstrual irregularities (P = 0.008). Moreover, we found significant difference in FAI level between the depressed and non depressed (p = 0.05), the anxious and non anxious patients (p < 0.001) compare to non affected PCOS women.

Conclusions

The high prevalence of depression and anxiety in this population suggests that initial evaluation of all women with PCOS should also include assessment of mental health disorders. The clinician should further pay attention to background of their patients especially in view of the factors influencing psychological well-being.

Keywords:
Anxiety; Depression; Quality of life; Polycystic ovary syndrome